ENTITY
Bayer

Bayer (BAYN GR)

69
Analysis
Health Care • Germany
Bayer AG produces and markets healthcare and agricultural products. The Company manufactures products that include aspirin, antibiotics, anti-infectives, cardiovascular, oncology, central nervous system drugs, over-the-counter medications, diagnostics, and animal health products, as well as crop protection products, plastics, and polyurethanes.
more
bearish•Monsanto Co
•09 Feb 2017 13:58

Monsanto / Bayer: International Antitrust Reviews

Antitrust regulators’ protocols and assessments of mergers differ by jurisdiction and this insight focuses almost exclusively on the international...

Share
•08 Feb 2017 01:38

If Reckitt Benckiser Buys Mead Johnson Then Is a Home Care Spinoff Next?

Reckitt Benckiser Group (RB) is currently in “advanced” talks to buy Mead Johnson Nutrition Co for USD16.7 billion, in a deal that makes little...

•30 Jan 2017 05:50

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

AML represents one of the largest hematologic cancer populations with one of the worst survival rates. Global prevalence is expected to increase at...

bearish•Nufarm Ltd
•25 Jan 2017 02:01

Our AUD 6.00 Nufarm Fair Value Estimate Stands Despite Share Price Strength

Our AUD 6.00 fair value estimate is unchanged. Nufarm shares have largely held on to the strong 40% price gains from AUD 6.30 February 2016 lows,...

Share
bearish•Syngenta AG
•23 Jan 2017 13:03

African Non-Profit to Fight Agrochem Mergers

The African Centre for Biodiversity (ACB), a Johannesburg-based non-profit organization promoting food sovereignty and campaigning against...

Logo
438 Views
Share
x